CTCAE Neutropenia Grade
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۵۰۰۰۰ • واحد: /mm³
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Grade 11–1
- Grade 22–2
- Grade 33–3
- Grade 44–4
The CTCAE Neutropenia Grade calculates staging malignant disease, estimating overall survival, and assessing chemotherapy tolerability. Key inputs include anc. Scores guide adjusting systemic antineoplastic regimens, planning supportive palliative measures, or targeted monitoring. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
CTCAE neutropenia grading from the absolute neutrophil count (ANC): Grade 1 (<LLN-1500), Grade 2 (<1500-1000), Grade 3 (<1000-500), Grade 4 (<500 /mm³). Standard oncology toxicity grading for chemotherapy decisions and growth-factor support.
Clinical Indication
The CTCAE Neutropenia Grade is indicated for bedside clinical practice to support CTCAE neutropenia grading from the absolute neutrophil count (ANC): Grade 1 (<LLN-1500), Grade 2 (<1500-1000), Grade 3 (<1000-500), Grade 4 (<500 /mm³). Standard oncology toxicity grading for chemotherapy decisions and growth-factor support.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.
Limitations & Contraindications
Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.
Clinical Pearls & Action Plan
Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival.
Grade by ANC thresholds (CTCAE v5)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| anc | float | Yes | Absolute neutrophil count(/mm³) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 1–1 | Grade 1 | Grade 1 |
| 2–2 | Grade 2 | Grade 2 |
| 3–3 | Grade 3 | Grade 3 |
| 4–4 | Grade 4 | Grade 4 |
| 0–0 | No neutropenia | No neutropenia |
Evidence-Based References (EBM)
- National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) v5.0. Neutrophil count decreased.